Citation Tools
PDFHealth economics
Original research
Cost-effectiveness analysis and budget impact of rivaroxaban compared with dalteparin in patients with cancer at risk of recurrent venous thromboembolism
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Cost-effectiveness analysis and budget impact of rivaroxaban compared with dalteparin in patients with cancer at risk of recurrent venous thromboembolism